Previous studies on high PRAME expression in SS, and reports on its interaction with EZH2 and RARs in melanoma and AML [18, 19] prompted us to analyze the expression of PRAME, EZH2, and the RAR genes in different soft-tissue sarcomas (STS). This evidence concerns the gene PRAME and soft tissue sarcoma.